• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

JCR Pharmaceuticals Co Ltd

+ Add to Watchlist


16.725 EUR 0.260 1.58%

As of 02:24:20 ET on 11/28/2014.

Snapshot for JCR Pharmaceuticals Co Ltd (JCR)

Open: 16.725 Day's Range: 16.725 - 16.725 Volume: 0
Previous Close: 16.465 52wk Range: 11.295 - 20.610 1-Yr Rtn: +35.56%

Stock Chart for JCR

No chart data available.
  • JCR:GR 16.725
  • 1M
  • 1Y
Interactive JCR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JCR

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 49.3069
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 49.9000
Est. PEG Ratio -
Market Cap (M EUR) 542.25
Shares Outstanding (M) 32.42
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.71%
Cash Dividend (JPY) 8.5000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 11.92%
Next Earnings Announcement 01/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JCR

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for JCR

JCR Pharmaceuticals Co., Ltd. develops, produces, and sells pharmaceutical products and raw materials. The Company also sells equipment for hospital and laboratory use. JCR Pharmaceuticals' products include drug for leukemic diseases and hormonal agents including genetically engineered human somatotrophic hormone (growth hormone) and gonadotropic hormone.

Shin AshidaChairman/Pres/CEO/COO/FounderKatsuya NishinoExecutive Vice President
Katsuhiko TachibanaSenior Managing DirectorHiroshi YoshimotoManaging Director
More Company Profile & Key Executives for JCR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil